BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 7963654)

  • 1. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma.
    Vowels BR; Lessin SR; Cassin M; Jaworsky C; Benoit B; Wolfe JT; Rook AH
    J Invest Dermatol; 1994 Nov; 103(5):669-73. PubMed ID: 7963654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
    Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
    J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells.
    Vowels BR; Cassin M; Vonderheid EC; Rook AH
    J Invest Dermatol; 1992 Jul; 99(1):90-4. PubMed ID: 1607682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides.
    Chong BF; Wilson AJ; Gibson HM; Hafner MS; Luo Y; Hedgcock CJ; Wong HK
    Clin Cancer Res; 2008 Feb; 14(3):646-53. PubMed ID: 18245523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Fujita H; Ohmatsu H; Kakinuma T; Kadono T; Tamaki K; Sato S
    J Invest Dermatol; 2010 Sep; 130(9):2304-11. PubMed ID: 20505746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell clones from early-stage cutaneous T-cell lymphoma show no polarized Th-1 or Th-2 cytokine profile.
    Harwix S; Zachmann K; Neumann C
    Arch Dermatol Res; 2000 Jan; 292(1):1-8. PubMed ID: 10664008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of interleukin-18 and caspase-1 in cutaneous T-cell lymphoma.
    Yamanaka K; Clark R; Dowgiert R; Hurwitz D; Shibata M; Rich BE; Hirahara K; Jones DA; Eapen S; Mizutani H; Kupper TS
    Clin Cancer Res; 2006 Jan; 12(2):376-82. PubMed ID: 16428475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA.
    Asadullah K; Döcke WD; Haeussler A; Sterry W; Volk HD
    J Invest Dermatol; 1996 Dec; 107(6):833-7. PubMed ID: 8941670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Morimura S; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Invest Dermatol; 2012 Apr; 132(4):1280-9. PubMed ID: 22297640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-7 mRNA is not overexpressed in mycosis fungoides and pleomorphic T-cell lymphoma and is likely to be an autocrine growth factor in vivo.
    Asadullah K; Haeussler A; Friedrich M; Siegling A; Olaizola-Horn S; Trefzer U; Volk HD; Sterry W
    Arch Dermatol Res; 1996 Dec; 289(1):9-13. PubMed ID: 9017129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas.
    Tensen CP; Vermeer MH; van der Stoop PM; van Beek P; Scheper RJ; Boorsma DM; Willemze R
    J Invest Dermatol; 1998 Aug; 111(2):222-6. PubMed ID: 9699721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis.
    Rook AH; Gottlieb SL; Wolfe JT; Vowels BR; Sood SS; Niu Z; Lessin SR; Fox FE
    Clin Exp Immunol; 1997 Jan; 107 Suppl 1():16-20. PubMed ID: 9020930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cells involved in psoriasis vulgaris belong to the Th1 subset.
    Schlaak JF; Buslau M; Jochum W; Hermann E; Girndt M; Gallati H; Meyer zum Büschenfelde KH; Fleischer B
    J Invest Dermatol; 1994 Feb; 102(2):145-9. PubMed ID: 8106745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity.
    Yoo EK; Cassin M; Lessin SR; Rook AH
    J Am Acad Dermatol; 2001 Aug; 45(2):208-16. PubMed ID: 11464181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of both circulating Th1 and Th2 T lymphocyte subsets in IgA nephropathy.
    Lai KN; Ho RT; Lai CK; Chan CH; Li PK
    Clin Exp Immunol; 1994 Apr; 96(1):116-21. PubMed ID: 7908616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
    Leroy S; Dubois S; Tenaud I; Chebassier N; Godard A; Jacques Y; Dréno B
    Br J Dermatol; 2001 May; 144(5):1016-23. PubMed ID: 11359391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
    Fivenson DP; Hanson CA; Nickoloff BJ
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    Clin Cancer Res; 2011 Dec; 17(24):7529-38. PubMed ID: 22048239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.